ENTOS
LIVE

Serial Number

97977591

Owner

ENTOS PHARMACEUTICALS INC.

Attorney

Theodore R. Remaklus

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ENTOS Trademark

Serial Number: 97977591 • Registration: 7446491

ENTOS is a trademark filed by ENTOS PHARMACEUTICALS INC. on September 14, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ENTOS PHARMACEUTICALS INC. (9 trademarks)

10230 JASPER AVENUE, UNIT 4550
EDMONTON, AB T5J4P6 , CA

Entity Type: 03

Trademark Details

Filing Date

September 14, 2022

Registration Date

July 16, 2024

First Use in Commerce

January 23, 2018

Published for Opposition

April 30, 2024

Goods & Services

Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies

Medical therapy services, namely, gene therapy services; medical analysis services, namely, RNA or DNA analysis for virus diagnosis and prognosis; medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; on-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; genetic testing for medical purposes

Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccines and medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products; scientific research, pharmaceutical research, medical research, technical consultation in the field of pharmaceutical studies and product development for others in the field of biotechnology and product development of pharmaceuticals, therapeutic agents and medical devices; research and product development in the field of human vaccines, recombinant proteins and antibodies for therapeutic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 4, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 12, 2024 XAEC
ASSIGNED TO LIE
Mar 11, 2024 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2024 CNEA
DIVISIONAL PROCESSING COMPLETE
Mar 8, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 6, 2024 AITU
DIVISIONAL REQUEST RECEIVED
Nov 16, 2023 DRRR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2023 TROA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 16, 2023 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 16, 2023 PARI
TEAS REQUEST TO DIVIDE RECEIVED
Nov 16, 2023 ERTD
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 27, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2022 NWOS
NEW APPLICATION ENTERED
Sep 17, 2022 NWAP